Comparison of the function of the serotonin transporter in the vasculature of male and female rats

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 5, 2011, Pages 314-322

  Linder, Aurea Elizabeth ^a   Davis, Robert Patrick ^b   Burnett, Robert ^b   Watts, Stephanie W ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Contractility; Platelet; Selective serotonin reuptake inhibitors

Indexed keywords

FLUVOXAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; CAROTID ARTERY; CAVA VEIN; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; JUGULAR VEIN; MALE; MINIPUMP; NONHUMAN; PROTEIN FUNCTION; RAT; SEROTONIN BLOOD LEVEL; VASCULARIZATION; WILD TYPE;

ANIMALS; AORTA; BLOOD PRESSURE; BLOOD VESSELS; FEMALE; HEART RATE; ISOMETRIC CONTRACTION; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RATS, WISTAR; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS;

EID: 79955444741     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05504.x     Document Type: Article

References (38)

1. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J. Affect. Disord. 2000; 58: 19-36.
2. Belik J. Fetal and neonatal effects of maternal drug treatment for depression. Semin. Perinatol. 2008; 32: 350-4.
3. Berlanga C, Flores-Ramos M. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. J. Affect. Disord. 2006; 95: 119-23.
4. Fleschler R, Peskin MF. Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: A review. MCN Am. J. Matern. Child Nurs. 2008; 33: 355-61.
5. Frank E, Thase ME, Spanier CA, Reynolds CF III, Kupfer DJ. Gender-specific response to depression treatment. J. Gend. Specif. Med. 1999; 2: 40-4.
6. Gorman JM. Gender differences in depression and response to psychotropic medication. Gend. Med. 2006; 3: 93-109.
7. Graziottin A, Serafini A. Depression and the menopause: Why antidepressants are not enough? Menopause Int. 2009; 15: 76-81.
8. Groer MW, Burns C. Stress response in female veterans: An allostatic perspective. Rehabil. Nurs. 2009; 34: 96-104.
9. Guidetti V, Albertson S, Galli F, Salvi E. Gender, migraine and affective disorders in the course of the life cycle. Funct. Neurol. 2009; 24: 29-40.
10. Varkukla M, Vignera AC, Gonsalves L. Depression and pregnancy. Compr. Ther. 2009; 35: 44-9.
11. Wassertheil-Smoller S, Shumaker S, Ockene J et al. Depression and cardiovascular sequela in postmenopausal women: The Women's Health Initiative (WHI). Arch. Intern. Med. 2004; 164: 289-98.
12. Weller EB, Kloos A, Kang J, Weller RA. Depression in children and adolescents: Does gender make a difference? Curr. Psychiatry Rep. 2006; 8: 108-14.
13. Yonkers KA. Special issues related to the treatment of depression in women. J. Clin. Psychiatry 2003; 64: 8-13.
14. Zender R, Olshansky E. Women's mental health: Depression and anxiety. Nurs. Clin. North Am. 2009; 44: 355-64.
15. Linder AE, Ni W, Szasz T et al. A serotonergic system in veins: Serotonin transporter-independent uptake. J. Pharmacol. Exp. Ther. 2008; 325: 714-22.
16. Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H1745-52.
17. Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW. The serotonin transporter is present and functional in peripheral arterial smooth muscle. J. Cardiovasc. Pharmacol. 2004; 43: 770-81.
18. Ni W, Geddes TJ, Priestley JR, Szasz T, Kuhn DM, Watts SW. The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. Br. J. Pharmacol. 2008; 154: 663-74.
19. Homberg JR, Olivier JDA, Smits BMG et al. Characterization of the serotonin transporter knockout rat: A selective change in the functioning of the serotonergic system. Neuroscience 2007; 146: 1662-76.
20. Diaz J, Ni W, Thompson J, King A, Fink GD, Watts SW. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J. Pharmacol. Exp. Ther. 2008; 325: 1031-8.
21. Brenner B, Harney JT, Ahmed BA et al. Plasma serotonin levels and the platelet serotonin transporter. J. Neurochem. 2007; 102: 206-15.
22. Lee HM, Hahn SJ, Choi BH. Inhibitory action of fluvoxamine on Kv1.5 currents. Biol. Pharm. Bull. 2010; 33: 977-82.
23. Watts SW. 5-HT in systemic hypertension: Foe, friend or fantasy? Clin. Sci. 2005; 108: 399-412.
24. Cox DA, Cohen ML. Influence of gender on vasomotor effects of oxidized low-density lipoprotein in porcine coronary arteries. Am. J. Physiol. 1997; 272: H2577-83.
25. Kahonen M, Tolvanen JP, Sallinen K, Wu X, Porsti I. Influence of gender on control of arterial tone in experimental hypertension. Am. J. Physiol. 1998; 275: H15-22.
26. Moyses MR, Barker LA, Cabral AM. Sex hormone modulation of serotonin-induced coronary vasodilation in isolated heart. Braz. J. Med. Biol. Res. 2001; 34: 949-58.
27. Nuno DW, Korovkina VP, England SK, Lamping KG. RhoA activation contributes to sex differences in vascular contractions. Arterioscler. Thromb. Vasc. Biol. 2007; 27: 1934-40.
28. Engel K, Wang J. Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol. Pharmacol. 2005; 68: 1397-407.
29. Gainetdinov RR, Caron MG. Monoamine transporters: From genes to behavior. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 261-84.
30. Barantke M, Krauss T, Ortak J et al. Effect of gender and aging on differential autonomic responses to orthostatic maneuvers. J. Cardiovasc. Electrophysiol. 2008; 19: 1296-303.
31. Hinosjosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, Sandberg K. Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 2004; 44: 405-9.
32. Sullivan JC, Semprun-Prieto L, Boesen EI, Pollock DM, Pollock JS. Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007; 293: R1573-9.
33. August P, Oparil S. Hypertension in women. J. Clin. Endocrinol. Metab. 1999; 84: 1862-6.
34. Amsterdam JD, Garcia-Espana F, Fawcett J et al. Blood pressure changes during short term fluoxetine. J. Clin. Psychopharmacol. 1999; 19: 9-14.
35. Grubb BP, Samoil D, Kosinski D, Wolfe D, Lorton M, Madu E. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am. J. Med. 1994; 97: 366-8.
36. Lazartigues E, Brefel-Courbon C, Bagheri H et al. Fluoxetine-induced pressor response in freely moving rats: A role for vasopressin and sympathetic tone. Fundam. Clin. Pharmacol. 2000; 14: 443-51.
37. Skop BF, Finkelstein JA, Mareth TR, Magoon MR, Brown TM. The serotonin syndrome associated with paroxetine, an over-the counter cold remedy, and vascular disease. Am. J. Emerg. Med. 1994; 12: 642-4.
38. Tsai ML, Lin MT. Hypertension and tachycardia produced by inhibition of reuptake of 5-hydroxytryptamine by fluoxetine in the rat. Neuropharmacology 1986; 25: 799-802.